Evaluation of Liver Function in Type 2 Diabetic Patients during Clinical Trials in Kirkuk City
[...]abnormalities in the consequences of liver function are more common among diabetics. [...]the ALT and AST test should be performed to examine the primary fatty liver, especially with diabetes, with a high BMI. According to a study conducted by Byrne C et al when interviewed 50 diabetic patients...
Gespeichert in:
| Veröffentlicht in: | Research journal of pharmacy and technology 2019-04, Vol.12 (4), p.1659-1663 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1663 |
|---|---|
| container_issue | 4 |
| container_start_page | 1659 |
| container_title | Research journal of pharmacy and technology |
| container_volume | 12 |
| creator | Azeez, Fadheelah S Saadi, Ali M |
| description | [...]abnormalities in the consequences of liver function are more common among diabetics. [...]the ALT and AST test should be performed to examine the primary fatty liver, especially with diabetes, with a high BMI. According to a study conducted by Byrne C et al when interviewed 50 diabetic patients with diabetes and 30 controls, ALT, AST, GGT, total protein and albumin were significantly higher in diabetics than in controls, although the average values were within the normal range. Liver function indicators for patients with type 2 diabetes were markedly higher than controls. 2. Because of high serum liver enzymes in type 2 diabetes patients, liver function tests is highly recommended to do. 3. |
| doi_str_mv | 10.5958/0974-360X.2019.00278.6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2271754392</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2271754392</sourcerecordid><originalsourceid>FETCH-LOGICAL-c145t-816aab2c24bff8f561ea614d1252eb4ef78a47f2827325474877a633ef37ea8d3</originalsourceid><addsrcrecordid>eNo9kF9LwzAUxYMoOOa-ggR8bs3_pI9SNxUH-jDBJ0PaJZKtpjNpB_v2tpvsvtzLueeeCz8AbjHKecHVPSoky6hAnzlBuMgRIlLl4gJMzovL84zVNZiltEFDCcUJUxPwNd-bpjedbwNsHVz6vY1w0Yf6qPgAV4edhQQ-elPZztfwffDa0CW47qMP37BsfPC1aeAqetOk8eTVx22_haXvDjfgyg2qnf33KfhYzFflc7Z8e3opH5ZZjRnvMoWFMRWpCaucU44LbI3AbI0JJ7Zi1kllmHREEUkJZ5IpKY2g1DoqrVFrOgV3p9xdbH97mzq9afsYhpeaEIklZ7Qgg0ucXHVsU4rW6V30PyYeNEZ6xKlHUnqkpkec-ohTC_oH5_RnhA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2271754392</pqid></control><display><type>article</type><title>Evaluation of Liver Function in Type 2 Diabetic Patients during Clinical Trials in Kirkuk City</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Azeez, Fadheelah S ; Saadi, Ali M</creator><creatorcontrib>Azeez, Fadheelah S ; Saadi, Ali M</creatorcontrib><description>[...]abnormalities in the consequences of liver function are more common among diabetics. [...]the ALT and AST test should be performed to examine the primary fatty liver, especially with diabetes, with a high BMI. According to a study conducted by Byrne C et al when interviewed 50 diabetic patients with diabetes and 30 controls, ALT, AST, GGT, total protein and albumin were significantly higher in diabetics than in controls, although the average values were within the normal range. Liver function indicators for patients with type 2 diabetes were markedly higher than controls. 2. Because of high serum liver enzymes in type 2 diabetes patients, liver function tests is highly recommended to do. 3.</description><identifier>ISSN: 0974-3618</identifier><identifier>EISSN: 0974-360X</identifier><identifier>EISSN: 0974-306X</identifier><identifier>DOI: 10.5958/0974-360X.2019.00278.6</identifier><language>eng</language><publisher>Raipur: A&V Publications</publisher><subject>Alcohol use ; Diabetes ; Enzymes ; Fatty acids ; Glucose ; Hepatitis ; Insulin resistance ; Liver cirrhosis ; Liver diseases ; Metabolic disorders ; Metabolic syndrome ; Obesity ; Oxidation ; Studies ; Weight control</subject><ispartof>Research journal of pharmacy and technology, 2019-04, Vol.12 (4), p.1659-1663</ispartof><rights>Copyright A&V Publications Apr 2019</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>Azeez, Fadheelah S</creatorcontrib><creatorcontrib>Saadi, Ali M</creatorcontrib><title>Evaluation of Liver Function in Type 2 Diabetic Patients during Clinical Trials in Kirkuk City</title><title>Research journal of pharmacy and technology</title><description>[...]abnormalities in the consequences of liver function are more common among diabetics. [...]the ALT and AST test should be performed to examine the primary fatty liver, especially with diabetes, with a high BMI. According to a study conducted by Byrne C et al when interviewed 50 diabetic patients with diabetes and 30 controls, ALT, AST, GGT, total protein and albumin were significantly higher in diabetics than in controls, although the average values were within the normal range. Liver function indicators for patients with type 2 diabetes were markedly higher than controls. 2. Because of high serum liver enzymes in type 2 diabetes patients, liver function tests is highly recommended to do. 3.</description><subject>Alcohol use</subject><subject>Diabetes</subject><subject>Enzymes</subject><subject>Fatty acids</subject><subject>Glucose</subject><subject>Hepatitis</subject><subject>Insulin resistance</subject><subject>Liver cirrhosis</subject><subject>Liver diseases</subject><subject>Metabolic disorders</subject><subject>Metabolic syndrome</subject><subject>Obesity</subject><subject>Oxidation</subject><subject>Studies</subject><subject>Weight control</subject><issn>0974-3618</issn><issn>0974-360X</issn><issn>0974-306X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNo9kF9LwzAUxYMoOOa-ggR8bs3_pI9SNxUH-jDBJ0PaJZKtpjNpB_v2tpvsvtzLueeeCz8AbjHKecHVPSoky6hAnzlBuMgRIlLl4gJMzovL84zVNZiltEFDCcUJUxPwNd-bpjedbwNsHVz6vY1w0Yf6qPgAV4edhQQ-elPZztfwffDa0CW47qMP37BsfPC1aeAqetOk8eTVx22_haXvDjfgyg2qnf33KfhYzFflc7Z8e3opH5ZZjRnvMoWFMRWpCaucU44LbI3AbI0JJ7Zi1kllmHREEUkJZ5IpKY2g1DoqrVFrOgV3p9xdbH97mzq9afsYhpeaEIklZ7Qgg0ucXHVsU4rW6V30PyYeNEZ6xKlHUnqkpkec-ohTC_oH5_RnhA</recordid><startdate>20190401</startdate><enddate>20190401</enddate><creator>Azeez, Fadheelah S</creator><creator>Saadi, Ali M</creator><general>A&V Publications</general><scope>AAYXX</scope><scope>CITATION</scope><scope>04Q</scope><scope>04S</scope><scope>04W</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20190401</creationdate><title>Evaluation of Liver Function in Type 2 Diabetic Patients during Clinical Trials in Kirkuk City</title><author>Azeez, Fadheelah S ; Saadi, Ali M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c145t-816aab2c24bff8f561ea614d1252eb4ef78a47f2827325474877a633ef37ea8d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Alcohol use</topic><topic>Diabetes</topic><topic>Enzymes</topic><topic>Fatty acids</topic><topic>Glucose</topic><topic>Hepatitis</topic><topic>Insulin resistance</topic><topic>Liver cirrhosis</topic><topic>Liver diseases</topic><topic>Metabolic disorders</topic><topic>Metabolic syndrome</topic><topic>Obesity</topic><topic>Oxidation</topic><topic>Studies</topic><topic>Weight control</topic><toplevel>online_resources</toplevel><creatorcontrib>Azeez, Fadheelah S</creatorcontrib><creatorcontrib>Saadi, Ali M</creatorcontrib><collection>CrossRef</collection><collection>India Database</collection><collection>India Database: Business</collection><collection>India Database: Science & Technology</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Research journal of pharmacy and technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Azeez, Fadheelah S</au><au>Saadi, Ali M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of Liver Function in Type 2 Diabetic Patients during Clinical Trials in Kirkuk City</atitle><jtitle>Research journal of pharmacy and technology</jtitle><date>2019-04-01</date><risdate>2019</risdate><volume>12</volume><issue>4</issue><spage>1659</spage><epage>1663</epage><pages>1659-1663</pages><issn>0974-3618</issn><eissn>0974-360X</eissn><eissn>0974-306X</eissn><abstract>[...]abnormalities in the consequences of liver function are more common among diabetics. [...]the ALT and AST test should be performed to examine the primary fatty liver, especially with diabetes, with a high BMI. According to a study conducted by Byrne C et al when interviewed 50 diabetic patients with diabetes and 30 controls, ALT, AST, GGT, total protein and albumin were significantly higher in diabetics than in controls, although the average values were within the normal range. Liver function indicators for patients with type 2 diabetes were markedly higher than controls. 2. Because of high serum liver enzymes in type 2 diabetes patients, liver function tests is highly recommended to do. 3.</abstract><cop>Raipur</cop><pub>A&V Publications</pub><doi>10.5958/0974-360X.2019.00278.6</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0974-3618 |
| ispartof | Research journal of pharmacy and technology, 2019-04, Vol.12 (4), p.1659-1663 |
| issn | 0974-3618 0974-360X 0974-306X |
| language | eng |
| recordid | cdi_proquest_journals_2271754392 |
| source | EZB-FREE-00999 freely available EZB journals |
| subjects | Alcohol use Diabetes Enzymes Fatty acids Glucose Hepatitis Insulin resistance Liver cirrhosis Liver diseases Metabolic disorders Metabolic syndrome Obesity Oxidation Studies Weight control |
| title | Evaluation of Liver Function in Type 2 Diabetic Patients during Clinical Trials in Kirkuk City |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T22%3A29%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20Liver%20Function%20in%20Type%202%20Diabetic%20Patients%20during%20Clinical%20Trials%20in%20Kirkuk%20City&rft.jtitle=Research%20journal%20of%20pharmacy%20and%20technology&rft.au=Azeez,%20Fadheelah%20S&rft.date=2019-04-01&rft.volume=12&rft.issue=4&rft.spage=1659&rft.epage=1663&rft.pages=1659-1663&rft.issn=0974-3618&rft.eissn=0974-360X&rft_id=info:doi/10.5958/0974-360X.2019.00278.6&rft_dat=%3Cproquest_cross%3E2271754392%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2271754392&rft_id=info:pmid/&rfr_iscdi=true |